Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 23 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Predicting renal function after orthotopic liver transplant

Duration of pretransplantation creatinine elevation, but not cause of renal dysfunction predicts renal outcome in orthotopic liver transplantation alone recipients, finds the most recent issue of Liver Transplantation.

News image

fiogf49gjkf04

In patients with recent onset renal insufficiency, the decision to perform combined kidney/liver transplantation vs orthotopic liver transplantation alone can be difficult.

Dr Rajender Reddy and colleagues hypothesized that duration of renal dysfunction may correlate with creatinine elevation after liver transplantation.

The researchers retrospectively identified 69 liver transplantation patients with pretransplantation creatinine 1.5 mg/dL.

The team included 53 patients with orthotopic liver transplantation alone, and 13 combined kidney/liver transplantation.

Variables analyzed were presence of hepatorenal syndrome, creatinine, Model for End-Stage Liver Disease score, and albumin levels.

The researchers also analyzed age, race, gender, cause of liver disease, diabetes mellitus, hypertension, history of ascites, and spontaneous bacterial peritonitis.

Creatinine levels in the orthotopic liver transplantation alone group were 2 mg/L
Liver Transplantation

In addition, variceal bleeding, hepatic encephalopathy, renal replacement therapy, and transjugular intrahepatic portosystemic shunting were assessed.

The team reported that duration of pretransplantation renal dysfunction was predictive of 6- and 12-month creatinine post- orthotopic liver transplantation alone.

The researchers found that area under the receiver operating characteristic curve for prediction of 12-month renal insufficiency by renal dysfunction duration was 0.7.

The team noted that optimal duration cutoff was 4 weeks.

A multivariable model was derived from patients with orthotopic liver transplantation alone.

The team applied this model to combined kidney/liver transplantation subjects with definite or possible hepatorenal syndrome.

The research team observed that predicted 12-month creatinine without renal transplantation was more than 2 mg/dL for each patient.

Combined kidney/liver transplantation patients as opposed to orthotopic liver transplantation alone patients had longer duration of renal dysfunction of 18 vs 3 weeks.

The team found that patients with combined kidney/liver transplantation had higher creatinine levels of 4 mg/dL vs 2 mg/dL in the orthotopic liver transplantation alone group.

Patients with combined kidney/liver transplantation had a higher rate of pretransplantation renal replacement therapy, of 62% vs 7%.

Combined kidney/liver transplantation patients had lower creatinine than orthotopic liver transplantation alone patients at 6 months and 12 months after transplantation.

Dr Rajender Reddy's team concluded, “Duration, but not cause, of renal dysfunction predicts renal outcome in orthotopic liver transplantation alone recipients.”

“Prospective studies may use duration of renal dysfunction to help identify combined kidney/liver transplantation candidates.”

Liv Transplant 2005: 11(9): 1048-55
30 August 2005

Go to top of page Email this page Email this page to a colleague

 23 February 2018 
MRI and NAFLD
 23 February 2018 
Heavy metals on a gluten-free diet
 23 February 2018 
Patients on antithrombotic agents undergoing emergency and elective endoscopy
 22 February 2018 
Autophagy enhancers
 22 February 2018 
Outcomes with Crohn’s after infliximab withdrawal
 22 February 2018 
Elderly onset of IBD

 21 February 2018 
Adalimumab and infliximab in biologic-naïve Crohn's
 21 February 2018 
Cystic fibrosis and colorectal cancer
 21 February 2018 
Management of hemorrhoids in the USA
 20 February 2018 
Treatment algorithm for polyp cancers
 20 February 2018 
Predictors of postoperative infection in Crohn's
 20 February 2018 
Complications and surveillance colonoscopies
 19 February 2018 
Screening colonoscopy in the right and left colon
 19 February 2018 
NAFLD prevalence in the USA
 19 February 2018 
Fructans in children with IBS

 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us